These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23857669)

  • 41. Quality of life: an assessment of the state of psychosocial rehabilitation of patients with schizophrenia in the community.
    Hasanah CI; Razali MS
    J R Soc Promot Health; 2002 Dec; 122(4):251-5. PubMed ID: 12557735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.
    Wilson CA; Koenig JI
    Eur Neuropsychopharmacol; 2014 May; 24(5):759-73. PubMed ID: 24342774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
    Rabinowitz J; Badescu S; Palamarchuk P; Filyk V; Voloshchuk A; Rud V; Melnyk E; Skrypnikov A; Davidson M; Saoud J; Luthringer R
    Schizophr Res; 2019 Sep; 211():103-104. PubMed ID: 31375316
    [No Abstract]   [Full Text] [Related]  

  • 44. Meta-analysis of physical activity and effects of social function and quality of life on the physical activity in patients with schizophrenia.
    Ohi K; Kataoka Y; Shimada T; Kuwata A; Okubo H; Kimura K; Yasuyama T; Uehara T; Kawasaki Y
    Eur Arch Psychiatry Clin Neurosci; 2019 Aug; 269(5):517-527. PubMed ID: 29789938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of labeling: blind and nonblind ratings of social skills in schizophrenic and nonschizophrenic control subjects.
    Lindsay WR
    Am J Psychiatry; 1982 Feb; 139(2):216-9. PubMed ID: 6119912
    [No Abstract]   [Full Text] [Related]  

  • 46. Clarifying pathways to poor psychological health: The mediating role of psychosocial factors in the relationship between general psychopathology and quality of life impairment in patients diagnosed with schizophrenia.
    Liu J; Abdin E; Verma S; Sim K; Chong SA; Subramaniam M
    J Clin Psychol; 2019 Jun; 75(6):1022-1033. PubMed ID: 30671966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and cognitive correlates of employment among patients with schizophrenia: a cross-sectional study in Malaysia.
    Midin M; Razali R; Zamzam R; Fernandez A; Hum LC; Shah SA; Radzi RS; Zakaria H; Sinniah A
    Int J Ment Health Syst; 2011 May; 5():14. PubMed ID: 21624111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies.
    Mojtabai R; Nicholson RA; Carpenter BN
    Schizophr Bull; 1998; 24(4):569-87. PubMed ID: 9853790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drugs and psychosocial treatment: editors' introduction.
    Mosher LR; Meltzer HY
    Schizophr Bull; 1980; 6(1):8-9. PubMed ID: 6102796
    [No Abstract]   [Full Text] [Related]  

  • 50. Predicting cognitive function of the Malaysian elderly: a structural equation modelling approach.
    Foong HF; Hamid TA; Ibrahim R; Haron SA; Shahar S
    Aging Ment Health; 2018 Jan; 22(1):109-120. PubMed ID: 27732054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychosocial disabilities in patients with schizophrenia.
    Goreishizadeh M; Mohagheghi A; Farhang S; Alizadeh L
    Iran J Public Health; 2012; 41(5):116-21. PubMed ID: 23113186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials.
    van der Meer L; Kaiser S; Castelein S
    Br J Psychiatry; 2021 Jul; 219(1):359-360. PubMed ID: 35048858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different antipsychotics produce similar, small improvements in psychosocial functioning at one year in people with schizophrenia.
    Heres S; Kissling W; Leucht S
    Evid Based Ment Health; 2007 Nov; 10(4):112. PubMed ID: 17962661
    [No Abstract]   [Full Text] [Related]  

  • 54. Designing New Psychosocial Treatments for Schizophrenia.
    Paul Liberman R; Corrigan PW
    Psychiatry; 1993 Aug; 56(3):238-249. PubMed ID: 27707110
    [No Abstract]   [Full Text] [Related]  

  • 55. Negative symptom dimensions and social functioning in Chinese patients with schizophrenia.
    Gao T; Huang Z; Huang B; Zhou T; Shi C; Yu X; Pu C
    Front Psychiatry; 2022; 13():1033166. PubMed ID: 36561640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-dimensional recording of long-term treatment of patients with schizophrenic disorders compared to patients with major depression measured with the ASSESS battery.
    Szyszko Vel Chorazy K; Efkemann SA; Schneider U; Juckel G
    Heliyon; 2022 Dec; 8(12):e11924. PubMed ID: 36471851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.
    Li Y; Zhang L; Zhang Y; Wen H; Huang J; Shen Y; Li H
    Neuropsychiatr Dis Treat; 2021; 17():847-857. PubMed ID: 33776440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship of psychological symptoms, antipsychotics and social data with psychosocial function in schizophrenia patients in Malaysia.
    Norlelawati AT; Kartini A; Norsidah K; Ramli M; Wan Azizi WS; Tariq AR
    Asia Pac Psychiatry; 2015 Mar; 7(1):45-53. PubMed ID: 23857669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.